Global Insomnia Market Size and Forecast 2023-2032|Pfizer Inc., Merck & Co Inc., Sanofi S.A., GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited,

The Insomnia Global Market Report 2023, provides comprehensive information on the insomnia market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.

Learn More On The Insomnia Market’s Growth:

The global insomnia market is expected to grow from $4.48 billion in 2022 to $4.72 billion in 2023 at a compound annual growth rate (CAGR) of 5.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The insomnia market is expected to reach $5.72 billion in 2027 at a CAGR of 4.9%.

Get A Free Sample Of The Report (Includes Graphs And Tables):

Product innovation is the key trend gaining popularity in the insomnia market. Major companies operating in the insomnia therapeutics market are developing innovative treatments to sustain their position in the market. For instance, in April 2023, WELT, a Korea-based medical device company, received approval from the Ministry of Food and Drug Safety (MFDS) for its digital insomnia treatment device, WELT-I. WELT-I was designated as an innovative medical aimed at correcting behavioral, psychological, and cognitive factors that sustain or worsen insomnia. The device delivers treatment based on cognitive behavioral therapy (CBT) as a first-line treatment in clinical guidelines for insomnia. The device is classified as a software as a medical device (SaMD), improving insomnia by performing personalized sleep time, analyzing sleep disturbance habits, intervening in patient behavior to enhance sleep quality, and delivering relaxation therapy for eight weeks to reduce tension and anxiety.

The insomnia market is segmented:

1) By Therapy Type: Non-Pharmacological Therapy, Pharmacological Therapy

2) By Drug Class: Anti-Depressants, Melatonin Antagonist, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist, Other Drug Classes

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

North America was the largest region in the insomnia market in 2022.

The table of contents in TBRC’s insomnia market report includes:

1. Executive Summary

2. Insomnia Market Characteristics

3. Insomnia Market Trends And Strategies

4. Insomnia Market – Macro Economic Scenario

5. Insomnia Market Segmentation




26. South America Insomnia Market

27. Brazil Insomnia Market

28. Middle East Insomnia Market

29. Africa Insomnia Market

30. Insomnia Market Competitive Landscape And Company Profiles

Top Major Players:

  • Pfizer Inc
  • Merck & Co Inc
  • Sanofi S.A
  • GlaxoSmithKline plc
  • akeda Pharmaceutical Company Limited

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:






Healthcare Blog:

Global Market Model:

Leave a Reply

Your email address will not be published. Required fields are marked *